Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

AJMC Q&A with Dr Sanjula Jain | Background image credit: ipopba – stock.adobe.com
Rethinking Diabetes Care: Are New Therapies Adding Value or Cost?

November 5th 2024

Sanjula Jain, PhD, chief research officer at Trilliant Health, discusses the rapid adoption of glucagon-like peptide 1 inhibitors for diabetes and preventive care for obesity and late-onset diabetes.

Aerial shot of neighborhood | Image credit: trekandphoto – stock.adobe.com
How Neighborhood Social Needs Drive Diabetes Care Disparities

October 18th 2024

Lifestyle and dietary changes have proven benefits for patients with diabetes, sometimes eliminating the need for their medications | image credit: Africa Studio - stock.adobe.com
The Off-Ramp: Novel Diabetes Reversal Program Bolsters Support of Nonpharmacological Disease Management

October 8th 2024

Diabetes | Image credit: Sherry Young – stock.adobe.com
What the Diabetes Health Economy Looks Like in 2024

October 1st 2024

Senate. | Image Credit: Corgarashu - stock.adobe.com
Semaglutide Accessibility and Affordability Addressed at Senate Committee Hearing

September 24th 2024

More News

Episode 10 - Drivers of Cost in Cardiometabolic Management
April 9th 2013

Episode 10 - Drivers of Cost in Cardiometabolic Management

Episode 9 - Current Challenges and Gaps in Patient Care
April 9th 2013

Episode 9 - Current Challenges and Gaps in Patient Care

Episode 8 - A Diverse Patient Population and Its Challenges
April 9th 2013

Episode 8 - A Diverse Patient Population and Its Challenges

Episode 7 - The Complex Equation of Management
April 9th 2013

Episode 7 - The Complex Equation of Management

Episode 6 - Diabetes and the Burden of Disease
April 9th 2013

Episode 6 - Diabetes and the Burden of Disease

Episode 5 - Setting the Tone: Current Therapeutic Goals
April 9th 2013

Episode 5 - Setting the Tone: Current Therapeutic Goals

Episode 4 - The Link Between Diabetes and Cardiovascular Disease
April 9th 2013

Episode 4 - The Link Between Diabetes and Cardiovascular Disease

Episode 2 - The Challenges of Disease Management: Clinician and Provider Perspectives
April 9th 2013

Episode 2 - The Challenges of Disease Management: Clinician and Provider Perspectives

Episode 3 - The Diversity of Patient Populations
April 9th 2013

Episode 3 - The Diversity of Patient Populations

Episode 1 - The Prevalence of Comorbid Cardiometabolic Disorders in the US
April 9th 2013

Episode 1 - The Prevalence of Comorbid Cardiometabolic Disorders in the US

Site Logo
March 13th 2013

Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants

William H. Herman, MD, MPH Sharon L. Edelstein, ScM Robert E. Ratner, MD Maria G. Montez, RN, MSHP Ronald T. Ackermann, MD, MPH Trevor J. Orchard, MD Mary A. Foulkes, PhD Ping Zhang, PhD Christopher D. Saudek, MD&dagger Morton B. Brown, PhD The Diabetes Prevention Program Research Group
Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.
Michael Farkouh, MD, Talks about the Prevention of Diabetes Mellitus
March 11th 2013

Michael Farkouh, MD, Talks about the Prevention of Diabetes Mellitus

Michael Farkouh, MD, Director of Clinical Trials and Associate Professor of Medicine, Mount Sinai School of Medicine, says that there are many strategies to both prevent and control diabetes mellitus, but he notes that obesity prevention is key.
Site Logo
March 7th 2013

Diabetes Costs Nation $245 Billion Annually, Study Says

Site Logo
February 17th 2013

Type 2 Diabetes and the Evolving Paradigm in Glucose Regulation

Muhammad A. Abdul-Ghani, MD, PhD
Site Logo
February 13th 2013

Are Benefits From Diabetes Self-Management Education Sustained?

JoAnn Sperl-Hillen, MD Sarah Beaton, PhD Omar Fernandes, MPH Ann Von Worley, RN, BSHS, CCRP Gabriela Vazquez-Benitez, PhD, MSc Ann Hanson, BS Jodi Lavin-Tompkins, RN, CNP, CDE, BC-ADM William Parsons, MS Kenneth Adams, PhD C. Victor Spain, DVM, PhD
Conventional individualized diabetes self-management education resulted in sustained improvement in self-efficacy and diabetes distress. Short-term improvements in A1C, nutrition, and physical activity were not sustained.
Site Logo
February 13th 2013

Do Electronic Medical Records Improve Diabetes Quality in Physician Practices?

Jeffrey S. McCullough, PhD Jon Christianson, PhD Borwornsom Leerapan, MD, PhD
Policy makers should not expect public sector electronic medical record investments to yield substantial short-term improvements in publicly reported measures.
Site Logo
February 12th 2013

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes

Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA
Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Site Logo
December 31st 2012

NOW AVAILABLE: A Special Report on Diabetes Innovation 2012

To act as a catalyst for ideas, partnerships, and collaboration among all stakeholders to provoke thought, innovation, and action to address the cost, productivity, and quality-of-life impact of diabetes, obesity, and related conditions and comorbidities on our society, Joslin Diabetes Center convened Diabetes Innovation for the first time in 2012. Highlights from Diabetes Innovation, which took place on September 23-25 2012, in Arlington, Virginia, are available in a special report published by The American Journal of Managed Care.
Site Logo
November 30th 2012

Introduction: Emerging Type 2 Diabetes Treatment Strategies: Practical Solutions for a Complex Environment

James T. Kenney, Jr, RPh, MBA
Site Logo
November 30th 2012

Achieving Antihyperglycemic Treatment Goals With Incretin-Related Therapies

Lawrence Blonde, MD, FACP, FACE
The management of type 2 diabetes mellitus (T2DM) remains challenging. Limitations associated with many current therapies include hypoglycemia and weight gain. An increased understanding of the pathophysiology of T2DM has led to the development of incretin-related antihyperglycemic therapies.
Site Logo
November 30th 2012

Evolving Strategies for Optimal Care Management and Plan Benefit Designs

John M. Cruickshank, DO, MBA, CPE
Site Logo
November 30th 2012

Managing the Evolving Complexity of Pharmacologic Treatment: Comparative Effectiveness Research, Pharmacoeconomic Data Analyses, and Other Decision Support Tools

James T. Kenney, Jr, RPh, MBA
Site Logo
November 30th 2012

Emerging Type 2 Diabetes Treatment Strategies: Practical Solutions for a Complex Environment

Site Logo
November 28th 2012

Participating Faculty: Emerging Type 2 Diabetes Treatment Strategies: Practical Solutions for a Complex Environment

Site Logo
November 20th 2012

Validating the Adapted Diabetes Complications Severity Index in Claims Data

Hsien-Yen Chang, PhD Jonathan P. Weiner, DrPH Thomas M. Richards, MSEE Sara N. Bleich, PhD Jodi B. Segal, MD, MPH
The aDCSI without the inclusion of laboratory data performs similarly to the DCSI with laboratory results, and is a good measure of diabetes severity.
Site Logo
October 25th 2012

Toward Tailored Disease Management for Type 2 Diabetes

Arianne M. J. Elissen, MSc Inge G. P. Duimel-Peeters, PhD Cor Spreeuwenberg, PhD Marieke Spreeuwenberg, PhD Hubertus J. M. Vrijhoef, PhD
The heterogeneous nature of care processes and patients should be taken into account in both the design and evaluation of disease management programs for diabetes.
Site Logo
October 5th 2012

VIDEO: Feng Zeng, PhD, Discusses Copayment Reduction in the Gap and Its Impact on Diabetes Medications

In this video, Feng Zeng, PhD, Senior Health Economist, MedImpact, discusses how the implementation of copayment reduction in the gap in 2011 influenced adherence measures for oral diabetes medications.
Site Logo
September 27th 2012

Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Jennie H. Best, PhD John A. Romley, PhD Dana P. Goldman, PhD Ryan M. Conrad, PhD Anne L Peters, MD
Site Logo
September 27th 2012

Participating Faculty: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Site Logo
September 19th 2012

Impact of Clinical Complexity on the Quality of Diabetes Care

LeChauncy D. Woodard, MD, MPH Cassie R. Landrum, MPH Tracy H. Urech, MPH Degang Wang, PhD Salim S. Virani, MD Laura A. Petersen, MD, MPH
We examined the impact of clinical complexity defined by comorbidity count and illness burden on comprehensive diabetes care, including blood pressure, glycemic, and lipid management.
<1
...
88899091929394959697>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo